Sector Charles River Laboratories International, Inc. Berne S.E.
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
End-of-day quote
Berne S.E.
03/09/2026
|
5-day change | 1st Jan Change | ||
| 233.98 CHF | +0.82% |
|
-3.43% | - |
| 08-20 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| 08-20 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.54% | -2.84% | +1.94% | +15.43% | +5.47% | -1.90% | +14.52% | -27.71% | +201.86% | 50.35B | |
| -1.24% | +0.23% | +7.70% | +33.83% | +161.59% | +434.94% | +518.46% | +576.93% | - | 45.2B | |
| -1.59% | +2.14% | +17.15% | +43.05% | +18.60% | +45.23% | +21.03% | +1.09% | +249.28% | 44.71B | |
| -1.10% | -2.14% | +11.11% | +28.21% | +18.13% | +12.60% | +75.21% | +3.55% | +1,105.50% | 41.24B | |
| +0.53% | -1.67% | +3.24% | +5.11% | +9.12% | +15.16% | +49.88% | -19.16% | +145.35% | 33.08B | |
| -1.03% | +8.08% | +9.54% | +22.43% | - | - | - | - | - | 17.81B | |
| +0.07% | -1.17% | +3.23% | +29.42% | +5.69% | +23.07% | +123.93% | +206.29% | +1,847.60% | 16.56B | |
| -1.01% | +0.50% | +5.67% | +11.81% | +16.54% | +15.83% | +27.98% | -41.39% | +92.30% | 14.82B | |
| -1.32% | -0.49% | +23.90% | +56.13% | +45.41% | +78.71% | +41.99% | -35.42% | +258.20% | 14B | |
| +0.30% | -3.09% | +5.05% | +7.83% | -9.58% | -6.57% | -36.30% | -37.00% | +119.31% | 12.62B | |
| -0.05% | +0.11% | +0.47% | +36.20% | +23.16% | +36.87% | -6.25% | -43.66% | +170.01% | 11.36B | |
| -0.16% | +0.46% | +36.73% | +23.10% | +8.94% | -17.65% | - | - | - | 11.67B | |
| -4.21% | -8.67% | +14.19% | +75.35% | +44.88% | +29.28% | +39.91% | -49.77% | - | 10.81B | |
| -1.56% | +0.21% | -10.21% | +16.26% | -18.94% | +34.07% | +453.29% | +194.42% | +2,370.89% | 10.78B | |
| +1.10% | -3.72% | +6.74% | -21.76% | -25.70% | -0.96% | +49.42% | +56.54% | +100.14% | 9.66B | |
| -13.33% | -11.33% | +93.01% | +134.43% | +153.30% | +81.43% | +71.16% | -12.00% | +1,200.00% | 10.13B | |
| -0.55% | +2.31% | +13.75% | +33.22% | +19.66% | +665.24% | +1,521.61% | +4.23% | - | 9.92B | |
| +0.45% | -1.02% | +12.02% | +56.74% | +50.29% | +177.11% | +487.64% | +84.91% | - | 9.75B | |
| -1.94% | +0.98% | +7.32% | +41.79% | +66.88% | +144.55% | +644.76% | +199.71% | +1,062.28% | 9.63B | |
| Average | -1.56% | -1.51% | +13.82% | +34.14% | +32.97% | +98.17% | +241.07% | +62.45% | +686.36% | 20.21B | |
| Weighted average by Cap. | -1.43% | -1.15% | +11.17% | +30.24% | +37.12% | +97.38% | +183.16% | +85.62% | +572.30% |
- Stock Market
- Stocks
- CRL Stock
- RV6 Stock
- Sector Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions
